Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung

Journal of Thoracic and Cardiovascular Surgery

Volumn 130, Issue 5, 2005, Pages 1378.e1-1378.e10

  Kim, Young Tae ^a   Sun, Jung Park ^b   Seung, Hee Lee ^b   Hee, Jung Kang ^b   Hahn, Seokyung ^b   Chang, Hyun Kang ^b   Sook, Whan Sung ^b   Joo, Hyun Kim ^b  

^a Seoul National University Hospital   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; GLUTATHIONE TRANSFERASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16INK4A; RETINOIC ACID RECEPTOR BETA;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CPG ISLAND; DNA DETERMINATION; DNA METHYLATION; FEMALE; FOLLOW UP; GENETICS; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; METHYLATION; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATHOLOGY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RISK FACTOR;

EID: 27544504703     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.06.015     Document Type: Article

References (24)

1. S.B. Baylin, J.G. Herman, J.R. Graff, P.M. Vertino, J.P. Issa Alterations in DNA methylation a fundamental aspect of neoplasia Adv Cancer Res 72 1998 141 196
2. A.K. Virmani, A. Rathi, S. Zochbauer-Muller, N. Sacchi, Y. Fukuyama, D. Bryant Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas J Natl Cancer Inst 92 2000 1303 1307
3. M. Esteller, S.R. Hamilton, P.C. Burger, S.B. Baylin, J.G. Herman Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Res 59 1999 793 797
4. M. Esteller, P.G. Corn, J.M. Urena, E. Gabrielson, S.B. Baylin, J.G. Herman Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia Cancer Res 58 1998 4515 4518
5. J.L. Kissil, E. Feinstein, O. Cohen, P.A. Jones, Y.C. Tsai, M.A. Knowles DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines possible implications for role as tumor suppressor gene Oncogene 15 1997 403 407
6. Y.T. Kim, S.H. Lee, S.W. Sung, J.H. Kim Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection? Ann Thorac Surg 79 2005 1180 1188
7. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin, S.B. Baylin Methylation-specific PCR a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci U S A 93 1996 9821 9826
8. R. Tanaka, D. Wang, Y. Morishita, Y. Inadome, Y. Minami, T. Iijima Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma Cancer 103 2005 608 615
9. R. Gonzalez-Quevedo, C. Garcia-Aranda, A. Moran, C. De Juan, A. Sanchez-Pernaute, A. Torres Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer clinical implications Int J Oncol 24 2004 349 355
10. J. Wang, J.J. Lee, L. Wang, D.D. Liu, C. Lu, Y.H. Fan Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer Clin Cancer Res 10 2004 6119 6125
11. T. Shimamoto, J.H. Ohyashiki, T. Hirano, H. Kato, K. Ohyashiki Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer potential prognostic implication Oncol Rep 12 2004 389 395
12. C. Lu, J.C. Soria, X. Tang, X.C. Xu, L. Wang, L. Mao Prognostic factors in resected stage I non-small-cell lung cancer a multivariate analysis of six molecular markers J Clin Oncol 22 2004 4575 4583
13. R. Maruyama, K. Sugio, I. Yoshino, Y. Maehara, A.F. Gazdar Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma Cancer 100 2004 1472 1477
14. D.H. Kim, J.S. Kim, Y.I. Ji, Y.M. Shim, H. Kim, J. Han Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer Cancer Res 63 2003 3743 3746
15. Y. Tomizawa, T. Kohno, H. Kondo, A. Otsuka, M. Nishioka, T. Niki Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma Clin Cancer Res 8 2002 2362 2368
16. Y.S. Chang, L. Wang, D. Liu, L. Mao, W.K. Hong, F.R. Khuri Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer Clin Cancer Res 8 2002 3669 3675
17. H. Hayashi, T. Yazawa, K. Okudela, J. Nagai, T. Ito, M. Kanisawa Inactivation of O6-methylguanine-DNA methyltransferase in human lung adenocarcinoma relates to high-grade histology and worse prognosis among smokers Jpn J Cancer Res 93 2002 184 189
18. S. Wolbach, P. Howe Tissue changes following deprivation of fat soluble A vitamin J Exp Med 42 1925 753 777
19. J.S. Kim, H. Lee, H. Kim, Y.M. Shim, J. Han, J. Park Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer J Clin Oncol 22 2004 3443 3450
20. M. Guo, M.G. House, C. Hooker, Y. Han, E. Heath, E. Gabrielson Promoter hypermethylation of resected bronchial margins a field defect of changes? Clin Cancer Res 10 2004 5131 5136
21. J.S. Kim, H. Kim, Y.M. Shim, J. Han, J. Park, D.H. Kim Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung Carcinogenesis 25 2004 2165 2171
22. D.H. Kim, H.H. Nelson, J.K. Wiencke, D.C. Christiani, J.C. Wain, E.J. Mark Promoter methylation of DAP-kinase association with advanced stage in non-small cell lung cancer Oncogene 20 2001 1765 1770
23. J.L. Ramirez, C. Sarries, P.L. de Castro, B. Roig, C. Queralt, D. Escuin Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients Cancer Lett 193 2003 207 216
24. S. Zochbauer-Muller, K.M. Fong, A.K. Virmani, J. Geradts, A.F. Gazdar, J.D. Minna Aberrant promoter methylation of multiple genes in non-small cell lung cancers Cancer Res 61 2001 249 255